Kenneth E. Lipson

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

Kenneth E. Lipson, Carol Wong, Yuchin Teng et al. · Fibrogenesis & Tissue Repair · 2012 · 578 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +17

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.

James G. Christensen, Randall Schreck, Jon Burrows et al. · PubMed · 2003 · 497 citations

Medicine, Oncology, Pharmacology +15

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis

Amir Abdollahi, Minglun Li, Ping Gong et al. · The Journal of Experimental Medicine · 2005 · 384 citations · Full text

Medicine, Oncology, Pharmacology +17

Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs et al. · European Journal of Heart Failure · 2019 · 294 citations · Full text

Medicine, Cardiology, Pathology +16

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

Amir Abdollahi, David W. Griggs, Heike Zieher et al. · Clinical Cancer Research · 2005 · 204 citations · Full text

Medicine, Oncology, Radiation Oncology +17